the license, development, supply and distribution agreement signed nov. 16, 2017, took great pains to say the following:
27.
NATURE OF THIS AGREEMENT
27.1
The Parties are independent contractors and none of the provisions of this Agreement shall be deemed to constitute a partnership or joint venture between the Parties. Neither Party shall have any authority to bind the other in any way.
Yet, in the January, 2023 Investor Presentation, oncy states:
Successful partnership with Adlai Nortye
• China, Hong Kong, Macau, Singapore, South Korea
and Taiwan
• Upfront and milestone payments of up to $86.6M
• $21M in milestone payments largely under
Oncolytics’ control, with double-digit royalties
• $65M tied to potential development expansion
wonder why? is it a partnership or isn't it? a partnership certainly has legal ramifications so wonder if there was some confidential change to the agreement. there are certainly a number of confidential provisions in the agreement, maybe this was changed without notification.
seems odd.